| Andrew Fahmy, MD | |
|
5400 Frantz Rd, Suite 250, Dublin, OH 43016-4144 | |
| (614) 544-6356 | |
| Not Available |
| Full Name | Andrew Fahmy |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine - Cardiovascular Disease |
| Location | 5400 Frantz Rd, Dublin, Ohio |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1104827336 | NPI | - | NPPES |
| 0270451 | Medicaid | OH |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RC0000X | Internal Medicine - Cardiovascular Disease | 35-16-2090-F (Ohio) | Primary |
| Entity Name | Ohiohealth Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1578545273 PECOS PAC ID: 6305758426 Enrollment ID: O20031105000532 |
News Archive
Sydney's iconic harbor has played a starring role in the development of new CSIRO technology that could save lives around the world.
Myelodysplastic/myeloproliferative neoplasms (MDS/MPN) is a group of rare malignancies with overlapping features from myelodysplastic syndromes (MDS) and myeloproliferative neoplasms (MPN), that include a variety of diseases depending on their phenotype (hematological and morphological characteristics).
A research team from Duke Health has developed an antibody from the body's own immune system that preferentially attacks cancer cells.
The prostate cancer program at the UCLA Jonsson Comprehensive Cancer Center and UCLA Health has been awarded an $8.7 million Specialized Program of Research Excellence, or SPORE, grant from the National Cancer Institute.
Since the outbreak of COVID-19, there has been a global surge in demand for nasopharyngeal (NP) swabs, a key element in testing for SARS-CoV-2. Singapore is no exception. Commercially available NP swabs used in COVID-19 test kits are often out of stock due to supply chain disruptions.
› Verified 3 days ago
| Entity Name | Ohiohealth Regional Physician Services Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1538552468 PECOS PAC ID: 9739496902 Enrollment ID: O20150921001772 |
News Archive
Sydney's iconic harbor has played a starring role in the development of new CSIRO technology that could save lives around the world.
Myelodysplastic/myeloproliferative neoplasms (MDS/MPN) is a group of rare malignancies with overlapping features from myelodysplastic syndromes (MDS) and myeloproliferative neoplasms (MPN), that include a variety of diseases depending on their phenotype (hematological and morphological characteristics).
A research team from Duke Health has developed an antibody from the body's own immune system that preferentially attacks cancer cells.
The prostate cancer program at the UCLA Jonsson Comprehensive Cancer Center and UCLA Health has been awarded an $8.7 million Specialized Program of Research Excellence, or SPORE, grant from the National Cancer Institute.
Since the outbreak of COVID-19, there has been a global surge in demand for nasopharyngeal (NP) swabs, a key element in testing for SARS-CoV-2. Singapore is no exception. Commercially available NP swabs used in COVID-19 test kits are often out of stock due to supply chain disruptions.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Andrew Fahmy, MD 5400 Frantz Rd, Suite 250, Dublin, OH 43016-4144 Ph: () - | Andrew Fahmy, MD 5400 Frantz Rd, Suite 250, Dublin, OH 43016-4144 Ph: (614) 544-6356 |
News Archive
Sydney's iconic harbor has played a starring role in the development of new CSIRO technology that could save lives around the world.
Myelodysplastic/myeloproliferative neoplasms (MDS/MPN) is a group of rare malignancies with overlapping features from myelodysplastic syndromes (MDS) and myeloproliferative neoplasms (MPN), that include a variety of diseases depending on their phenotype (hematological and morphological characteristics).
A research team from Duke Health has developed an antibody from the body's own immune system that preferentially attacks cancer cells.
The prostate cancer program at the UCLA Jonsson Comprehensive Cancer Center and UCLA Health has been awarded an $8.7 million Specialized Program of Research Excellence, or SPORE, grant from the National Cancer Institute.
Since the outbreak of COVID-19, there has been a global surge in demand for nasopharyngeal (NP) swabs, a key element in testing for SARS-CoV-2. Singapore is no exception. Commercially available NP swabs used in COVID-19 test kits are often out of stock due to supply chain disruptions.
› Verified 3 days ago
Dr. Thomas C. Ransbottom, MD Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 6670 Perimeter Dr, Suite 200, Dublin, OH 43016 Phone: 614-754-5500 Fax: 614-754-5501 | |
Owen Johnson, M.D. Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 3118 Barry Trace Ct, Dublin, OH 43017 Phone: 614-389-3063 Fax: 614-389-3063 | |
Neha Kumar, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 5070 Bradenton Ave, Dublin, OH 43017 Phone: 614-764-1777 Fax: 614-764-9555 | |
Seth M Kantor, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 3900 Stoneridge Ln, Dublin, OH 43017 Phone: 614-798-7905 Fax: 614-798-7952 | |
Dan N Spetie, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 3900 Stoneridge Ln, Dublin, OH 43017 Phone: 614-293-4997 Fax: 614-293-3073 | |
Douglas M. Magorien, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 3900 Stoneridge Ln Ste A, Dublin, OH 43017 Phone: 614-293-7677 Fax: 614-293-5614 |